Talbot George Harrison
Insider CIK 1554194 · NBRV Director · NBRV Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| NBRV Nabriva Therapeutics plc | A Award deriv | 2020-07-29 | 2020-07-31 | 35,000 | — | $0 | 35,000 | SEC↗ |
| NBRV Nabriva Therapeutics plc | A Award | 2020-07-29 | 2020-07-31 | 17,500 | — | $0 | 65,140 | SEC↗ |
| NBRV Nabriva Therapeutics plc | A Award deriv | 2019-07-31 | 2019-08-01 | 35,000 | — | $0 | 35,000 | SEC↗ |
| NBRV Nabriva Therapeutics plc | P Buy | 2018-07-31 | 2018-08-02 | 14,500 | $2.75 | $39.9K | 47,640 | SEC↗ |
| NBRV Nabriva Therapeutics plc | A Award deriv | 2018-05-02 | 2018-05-04 | 29,000 | — | $0 | 29,000 | SEC↗ |
| NBRV Nabriva Therapeutics plc | M Exercise deriv | 2017-09-27 | 2017-09-29 | 1,350 | — | $0 | 0 | SEC↗ |
| NBRV Nabriva Therapeutics plc | M Exercise | 2017-09-27 | 2017-09-29 | 1,350 | — | $0 | 33,140 | SEC↗ |
| NBRV Nabriva Therapeutics plc | A Award deriv | 2017-09-15 | 2017-09-19 | 10,100 | — | $0 | 10,100 | SEC↗ |
| NBRV Nabriva Therapeutics Plc | J Other deriv | 2017-06-23 | 2017-06-27 | 40,000 | — | $0 | 40,000 | SEC↗ |
| NBRV Nabriva Therapeutics Plc | J Other deriv | 2017-06-23 | 2017-06-27 | 10,100 | — | $0 | 10,100 | SEC↗ |
| NBRV Nabriva Therapeutics Plc | J Other | 2017-06-23 | 2017-06-27 | 31,790 | — | $0 | 31,790 | SEC↗ |
| NBRV Nabriva Therapeutics AG | S Sale | 2017-06-19 | 2017-06-19 | 46 | $91.00 | $4.2K | 3,179 | SEC↗ |
| NBRV Nabriva Therapeutics AG | S Sale | 2017-06-16 | 2017-06-19 | 24 | $93.50 | $2.2K | 3,225 | SEC↗ |
| NBRV Nabriva Therapeutics AG | S Sale | 2017-06-15 | 2017-06-19 | 100 | $94.10 | $9.4K | 3,249 | SEC↗ |
| NBRV Nabriva Therapeutics AG | S Sale | 2017-05-30 | 2017-06-01 | 110 | $101.50 | $11.2K | 3,449 | SEC↗ |
| NBRV Nabriva Therapeutics AG | S Sale | 2017-05-30 | 2017-06-01 | 100 | $101.00 | $10.1K | 3,349 | SEC↗ |
| NBRV Nabriva Therapeutics AG | S Sale | 2017-05-25 | 2017-05-25 | 90 | $101.00 | $9.1K | 3,559 | SEC↗ |
| NBRV Nabriva Therapeutics AG | S Sale | 2017-05-25 | 2017-05-25 | 205 | $100.50 | $20.6K | 3,649 | SEC↗ |
| NBRV Nabriva Therapeutics AG | S Sale | 2017-05-23 | 2017-05-25 | 30 | $99.70 | $3.0K | 3,854 | SEC↗ |
| NBRV Nabriva Therapeutics AG | S Sale | 2017-05-16 | 2017-05-17 | 50 | $102.27 | $5.1K | 3,984 | SEC↗ |
| NBRV Nabriva Therapeutics AG | S Sale | 2017-05-16 | 2017-05-17 | 100 | $103.00 | $10.3K | 3,884 | SEC↗ |
| NBRV Nabriva Therapeutics AG | S Sale | 2017-05-15 | 2017-05-17 | 50 | $101.50 | $5.1K | 4,034 | SEC↗ |
| NBRV Nabriva Therapeutics AG | M Exercise deriv | 2017-02-16 | 2017-05-17 | 155 | — | $0 | 0 | SEC↗ |
| NBRV Nabriva Therapeutics AG | M Exercise deriv | 2017-02-16 | 2017-05-17 | 578 | — | $0 | 135 | SEC↗ |
| NBRV Nabriva Therapeutics AG | M Exercise deriv | 2017-02-16 | 2017-05-17 | 502 | — | $0 | 0 | SEC↗ |
| NBRV Nabriva Therapeutics AG | M Exercise | 2017-02-16 | 2017-05-17 | 578 | — | $0 | 4,084 | SEC↗ |
| NBRV Nabriva Therapeutics AG | M Exercise | 2017-02-16 | 2017-05-17 | 502 | — | $0 | 3,351 | SEC↗ |
| NBRV Nabriva Therapeutics AG | M Exercise | 2017-02-16 | 2017-05-17 | 155 | — | $0 | 3,506 | SEC↗ |